APACC 2020

Coronavirus Update - 31 March

As of March 2020, APACC 2020 has been postponed and will take place from 15 to 17 October 2020

  • Registrants that are able to attend the new dates will automatically have their registration re-assigned to the new dates. If you are not able to attend, we will refund 100% of your registration fee. Please contact us if you need to cancel your participation by 30 June.
  • If you have submitted an abstract, please note that the new abstract submission deadline is Friday, 31 July. Please let us know if you would like to withdraw and re-submit your abstract. 
  • If you have submitted an abstract, your existing abstract submission will remain valid and will be scored at a later stage.  Please let us know if you would like to withdraw and re-submit your abstract. The new abstract deadline is Friday, 31 July. You will be informed about the outcome no later than two months prior to the start of the conference.
  • The new scholarship application deadline is Monday, 3 August
  • The dates for the pre-events: Asia Pacific HIV Clinical Forum and Asian Stigma & Discrimination Forum have been re-scheduled consequently.  

We are available to answer any questions or concerns that you may have about your participation at APACC 2020. For more information, please contact Mr. Kun-Chieh Wu at kun-chieh@vironet.com.

To stay updated on developments about APACC 2020, make sure you are signed up for our newsletter


Welcome Message 

Dear colleagues,

It is our pleasure to announce that the Asia Pacific AIDS & Co-Infections Conference (APACC) 2020 is scheduled to take place in Bangkok, Thailand on 15 - 17 October 2020.

Over the years, enormous progress has been made in the fight against HIV and co-infections with HIV. Both academia and industry have contributed greatly to equipping the medical community with the best medications and expertise possible to optimally treat their HIV and co-infected patients. However, the international platforms for scientific interchange are not always accessible to medical professionals worldwide due to budget and travel restrictions. Also, most major conferences do not usually address local and regional issues. In particular, the Asian medical community in this field of research currently has very few platforms that serve the needs of HIV healthcare professionals in this region.

APACC provides a much-needed scientific platform that focuses on the developments, issues, and needs in the Asia Pacific region. Researchers have the opportunity to present and discuss the latest developments and are offered opportunities for interaction, networking, and building collaborations. Top experts integrate science and clinical practice through state-of-the-art lectures, clinical case discussions, round table discussions, and debates in order to reach consensus on best practices and inform how treatment guidelines are implemented.

We look forward to welcoming you at APACC 2020!

Chairs 2020


Unique Features

  • A program with a special focus on the needs in Asia and the Pacific
  • A true scientific platform for regional clinicians and clinical researchers to present their data
  • Insights into important clinical developments and updates on ongoing and new trials
  • Capacity building workshops and career development sessions for young professionals
  • A great opportunity to network with your colleagues throughout Asia

Who Should Attend?

  • Medical professionals involved in the daily care of individuals infected with HIV and HIV-HCV, HIV-HBV, HIV-TB, and other HIV co-infections
  • Clinical, translational, and basic researchers
  • Clinicians, physicians, general practitioners, and nurses
  • Residents, post-graduates, and PhD students
  • Government agency personnel, NGO representatives, and  health authority personnel
  • Industry representatives
  • Social workers, advocates, and community workers
  • Other healthcare professionals involved in treating HIV and co-infected patients

Meeting Objectives

This meeting aims to:

  • Promote dissemination and successful translation of new knowledge regarding HIV and co-infections while facilitating a neutral environment
  • Foster new and lasting cross-disciplinary partnerships and collaborations between researchers in HIV, hepatitis, tuberculosis, policymakers, and NGOs, among others, in order to improve  knowledge sharing, with the end goal of improving healthspan within the rapidly growing HIV/AIDS population
  • Attract, showcase, and maintain new, early career, and underrepresented investigators to this multidisciplinary area of research and to translate novel findings into clinical practice

Learning Objectives

After participating in this activity, the participants will be able:

  • Describe the major achievements and challenges in antiviral therapy for HIV and/or hepatitis-positive patients in the Asia Pacific region 
  • Identify improved treatment options for their patients
  • Initiate (research) collaborations to further improve the level of knowledge on clinical management in the Asia Pacific region
  • Use gained knowledge to make/advocate for appropriate adjustments to policies in public, institutional, and private settings